Cocrystal Pharma
A clinical-stage biotechnology company developing novel antiviral therapeutics.
Last updated September 1, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel broad-spectrum antiviral therapeutics that target the replication process of influenza virus, coronaviruses (including SARS-CoV-2 and MERS), norovirus, and hepatitis C virus.
History
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel broad-spectrum antiviral therapeutics that target the replication process of influenza virus, coronaviruses (including SARS-CoV-2 and MERS), norovirus, and hepatitis C virus.
Sources5 sources
Cite this profile: Cite the canonical profile. /brand-wiki/cocrystal-pharma · Editorial policy · How profiles are compiled